Chronic inflammatory demyelinating polyneuropathy following treatment with peglated interferon alpha-2a for chronic hepatitis C virus infection.

摘要

The etiopathogenisis of chronic inflammatory demyelinating polyneuropathy (CIDP) is unknown yet. Peglated interferon alpha-2a is an antiviral biological agent, which is widely used to treat chronic viral hepatitis. Although neurological complications such as myasthenia gravis, axonal neuropathy, and central nervous system demyelination have been reported during interf eron-alpha therapy, CIDP is rarely reported. Here, we report a patient with chronic hepatitis C virus (HCV) infection, who developed CIDP during treatment with Peglated interferon alpha-2a.